Supporting Multiple Global Gene Therapy Studies for Rare Diseases
A long-term client called upon the Veristat team for help conducting two investigational Phase I/II studies. These global studies focused on proving the safety and efficacy of gene therapy for two rare genetic disorders. Working side-by-side with the client, our cell and gene therapy experts addressed many complicated challenges – including site start-up issues, stringent regulatoryrequirements, and the logistics of handling highly sensitive genetic material. Learn about the challenges that were overcome to get to first-patient -in.
downloadExplore Our Key Related Services
Please fill out this form to access your resource.